|
Marksans Pharma Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
14610.00 Cr.
|
P/BV
|
4.59
|
Book Value (Rs.)
|
70.23
|
|
52 Week High/Low (Rs.)
|
346/155
|
FV/ML
|
1/1
|
P/E(X)
|
34.96
|
|
Bookclosure
|
20/08/2026
|
EPS (Rs.)
|
9.22
|
Div Yield (%)
|
0.28
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 560.56 | 503.97 | 423.53 | 337.65 | 247.51 |
| | | | | | |
| Net CashFlow From Operating Activities | 458.13 | 206.66 | 230.41 | 237.41 | 99.26 |
| Net Cash Used In Investing Activities | -248.27 | -49.01 | -140.84 | -259.21 | -41.69 |
| Net Cash Used From Financing Activities | -70.93 | -65.15 | -68.73 | 197.83 | 79.51 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 138.93 | 92.51 | 20.84 | 176.03 | 137.08 |
| Cash And Cash Equivalents Begin of Year | 495.21 | 403.28 | 382.44 | 206.41 | 212.18 |
| Cash And Cash Equivalents End Of Year | 634.14 | 495.79 | 403.28 | 382.44 | 349.27 |